Treatment News : New Pneumococcal Vaccine Recs for People Living with HIV

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » October 2012

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


October 18, 2012

New Pneumococcal Vaccine Recs for People Living with HIV

People living with HIV should receive two different vaccines to help prevent serious strep-related illness, according to new recommendations by the Advisory Committee on Immunization Practices (ACIP) published October 12 in the U.S. Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly.  In addition to the long-standing recommendation that people with “immunocompromising conditions” 19 years of age and older receive Pneumovax 23 (23-valent pneumococcal polysaccharide vaccine, or PPSV23), ACIP now recommends the addition of Prevnar 13 (13-valent pneumococcal conjugate vaccine, or PCV13).  

The CDC notes that Streptococcus pneumonia remains a leading cause of serious illness, including infection of the blood (bacteremia), meningitis and pneumonia in the U.S., particularly among people living with HIV and other chronic health conditions.  

Adults living with HIV who have already received the Pneumovax-23 vaccine should speak with their health care providers about receiving the Prevnar 13 vaccine.  Prevnar 13 should be given no sooner than one year after Pneumovax 23 was last administered. Conversely, adults living with HIV who have not received either vaccine should first receive Prevnar 13, followed by Pneumovax 23 eight weeks later.

To read the ACIP recommendations, click here.

Search: pneumococcal, vaccine, strep, streptococcus pneumoniae, pneumovax 23, prevnar 13, 23-valent pneumococcal polysaccaride vaccine, 13-valent conjugate vaccine, ppsv23, pcv13, bacteriemia, meningitis, pneumonia

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (1 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.